Home » Topics » BioWorld Science

BioWorld Science
RSS

Pfizer terminates two ongoing domagrozumab studies for DMD

Aug. 31, 2018

Thanks for the memories: In bacteria, protein aggregates can protect from stress

Aug. 31, 2018

FDA approves Jivi for hemophilia A

Aug. 31, 2018

New preterm labor is drug safe with favorable pharmacokinetic profile

Aug. 31, 2018

PLIN2 is a putative tumor suppressor and prognostic marker of renal cell carcinoma

Aug. 31, 2018

Renin inhibitor TAK-272 developed at Takeda for heart failure

Aug. 31, 2018

Blincyto approved for use in pediatric patients with Ph- relapsed or refractory B-cell precursor ALL

Aug. 30, 2018

First patient dosed in phase II clinical trial in Duchenne muscular dystrophy

Aug. 30, 2018

Poxel acquires DRX-065 and portfolio of additional deuterated drug candidates

Aug. 30, 2018

Sophiris Bio announces update on phase IIb trial in localized prostate cancer

Aug. 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...